"A world-wide prospective study of INC on prognosis and biomarkers in GBS"

A world-wide prospective study of INC on prognosis and biomarkers in GBS

Number of inclusions @ 6 May 2020

1901!                               More >>

Publication success

We are excited to announce the acceptance/publication of three IGOS-related papers
  1. Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomized ISID study, Verboon, et al, Journal of Neurology, Neurosurgery, and Psychiatry
  2. Current treatment practice of Guillain-Barré syndrome, Verboon, et al, Neurology
  3. Diagnosis and management of Guillain–Barré syndrome in ten steps, Leonhard et al, Nature Reviews Neurology
More >>
More news

Privacy Statement

Information regarding the General Data Protection Regulation for participants in
clinical research, for which Erasmus MC is the sponsor.

Since 25 May 2018 the General Data Protection Regulation (AVG) applies. The AVG describes the rights with regard to access, modification and deletion of personal data. This regulation does not affect the research itself. The way in which the researcher, Erasmus MC, handles your data is described in the patient information you received before the start of the study.

As a participant in scientific research, we would like to inform you about the changes:
You have the right at all times to view, change or withdraw your consent for the use of your personal data. The research data collected until the moment you withdraw your permission will still be used in the study. After your consent has been withdrawn, your biological material (if applicable) will be destroyed. If measurements have already been made with this biological material, this data will still be used.

For general information about your rights when processing your personal
data, you can consult the website of the Dutch Data Protection Authority

For more information or questions about your rights, please contact the
Data Protection Officer via the secretariat of the Legal Affairs  Department, telephone number 010-7034986 or the Dutch Data Protection Authority.